European Pharmaceutical Review
FEBRUARY 21, 2025
New clinical research from the UK has revealed the significant potential of a gene therapy to treat young children with AIPL1-related retinal dystrophy. Findings of the first-in-human study, published in The Lancet , reported that the four children with the rare genetic deficiency benefited substantially, as they gained strong improvements in their eyesight.
STAT
FEBRUARY 21, 2025
The Maryland House of Delegates has voted overwhelmingly to allow a state board to extend its mandate for lowering prescription drug costs to all residents, not just those employed by government agencies. As a result, the initiative now goes to the state senate for approval, although the timing is unclear. Nonetheless, the 98-to-34 vote was cheered by consumer advocates who hope the Prescription Drug Affordability Board, which is designed to function much like a state utility commission, will us
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Mirror
FEBRUARY 21, 2025
As a provider of custom services, Creative Biolabs aims to support the entire process of drug discovery and development for the global pharmaceutical industry using its cutting-edge technology and wide-ranging experiences. It is no secret that the complexities associated with biopharmaceuticals are ever increasing, particularly regarding the development of antibody therapeutics.
Drug Topics
FEBRUARY 21, 2025
Measles is highly contagious, and the Texas Department of State Health Services said that additional cases are likely to occur in Gaines County, which had 57 cases as of February 21, 2025.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
PharmaVoice
FEBRUARY 21, 2025
"Any place that gets cut, it's going to have an impact, because there's not any spare personnel at FDA,” said former agency commissioner Robert Califf, of the layoffs.
Drug Topics
FEBRUARY 21, 2025
Pharmacists who participated in the mental health first aid training had better understanding of mental health conditions and increased confidence and skills in mental health intervention.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Drug Topics
FEBRUARY 21, 2025
Ctexli is the first FDA-approved treatment for adults with cerebrotendinous xanthomatosis.
Fierce Healthcare
FEBRUARY 21, 2025
Congress and state leaders must resist short-term cost-cutting measures that cause long-term harm, create cycles of poverty and dismantle the middle class.
Drug Topics
FEBRUARY 21, 2025
Physician with expertise in pain research discussed emerging technologies in the future of pain medicine and how they must be adapted to improve patient outcomes.
Pharmacy Times
FEBRUARY 21, 2025
In a study of 5 different drugs, amlodipine was the only one to reduce hyperactivity in patients with attention-deficit hyperactivity disorder (ADHD).
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Topics
FEBRUARY 21, 2025
Semaglutide has been in shortage since 2022 due to increased demand.
STAT
FEBRUARY 21, 2025
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. I’m back after a two-week India trip, but mentally I am still scrambling up slopes in the Himalayan foothills. Please send your favorite chai recipes.
Fierce Healthcare
FEBRUARY 21, 2025
The Department of Justice is probing UnitedHealth Group's billing practices in Medicare Advantage, according to a report from the Wall Street Journal.
Pharmacy Times
FEBRUARY 21, 2025
Melody Smith, MD, MS, discusses how the intestinal microbiome influences CAR T-cell therapy outcomes, highlighting the negative impact of certain antibiotics and the potential role of dietary interventions in improving treatment efficacy.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Fierce Healthcare
FEBRUARY 21, 2025
The AI agents have access to a 360-degree view of patient information drawn from unified clinical and claims data and can handle tasks such as scheduling, follow-ups and care coordination.
Pharmacy Times
FEBRUARY 21, 2025
The approach targets cancer glucose and fatty acid metabolism, which is essential for cancer cell growth.
Fierce Healthcare
FEBRUARY 21, 2025
Staffing difficulties and population growth will cut down the number of open acute care hospital beds over the next decade should hospitalization rates and other trends remain unchanged, new projections show.
Pharmaceutical Technology
FEBRUARY 21, 2025
Pfizer said resources will be directed to its other haemophilia gene therapy Hympavzi.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Healthcare
FEBRUARY 21, 2025
CVS Health's MinuteClinic and Georgia-based Emory Healthcare are expanding their partnership to provide in-network primary care services at the retail clinics.
Pharmacy Times
FEBRUARY 21, 2025
This marks the first treatment to be FDA-approved for this rare lipid storage disease.
pharmaphorum
FEBRUARY 21, 2025
A proposed merger of the UK's Poolbeg with Austrian biotech Hookipa has been called off after the latter abruptly withdrew from negotiations.
Pharmacy Times
FEBRUARY 21, 2025
The AACR Immunotherapy Conference 2025 will provide pharmacists with the opportunity to engage with cutting-edge cancer immunotherapy research, explore advancements in treatments, such as immune checkpoint inhibitors and CAR T-cell therapy, and connect with key leaders in the field.
pharmaphorum
FEBRUARY 21, 2025
Cell therapies show great promise for revolutionising healthcare, but challenges remain in scaling up production. Learn more about the current obstacles and potential solutions in this informative article.
Pharmacy Times
FEBRUARY 21, 2025
SkinTE could aid Wagner grade 1 diabetic foot ulcers by regenerating and activating the tissues surrounding the wound to heal it completely.
pharmaphorum
FEBRUARY 21, 2025
The reporting week has ended with a flurry of M&A as Cosette Pharma and AstraZeneca agree takeover deals
Pharmacy Times
FEBRUARY 21, 2025
The new data demonstrates the effectiveness of Mim8 in children with hemophilia A regardless of inhibitor status, expanding the populations in which the novel drug in development could have a treatment benefit.
Pharmaceutical Commerce
FEBRUARY 21, 2025
James D. Chambers, PhD, MPharm, MSc, professor of medicine at the Tufts Medical Center Institute for Clinical Research and Health Policy Studies, dives into why biosimilars contribute to a reduction in cost and increase in patient access, while highlighting challenges to adoption.
pharmaphorum
FEBRUARY 21, 2025
Boehringer's cystic fibrosis gene therapy is poised to start clinical testing, hoping to offer a one-shot alternative to costly CFTR modulator drugs.
Fierce Healthcare
FEBRUARY 21, 2025
Millie plans to expand its footprint and add more services, fueled by a $12 million series A funding round. The company will soon open its second clinic in San Francisco's South Bay in collaboration with Good Samaritan Hospital, part of HCA Healthcare.
Pharmacy Times
FEBRUARY 21, 2025
Plasma therapy can involve burdensome procedures and infusions for patients, but pharmacists can use their expertise to make the process easier and more convenient.
Pharmaceutical Technology
FEBRUARY 21, 2025
Glucagon-like peptide-1 receptor agonists (GLP-1RAs), originally developed for treating diabetes, work by stimulating insulin secretion and suppressing glucagon release, thereby helping regulate blood sugar.
Pharmacy Times
FEBRUARY 21, 2025
Using chromosome genomic array testing in combination with existing risk stratification models can better determine patients with myelofibrosis who can benefit from transplant.
Pharmaceutical Technology
FEBRUARY 21, 2025
Bluebird has faced financial pressures over the last few years, leading to several restructuring efforts.
Expert insights. Personalized for you.
Let's personalize your content